Literature DB >> 27857623

Cannabidiol Mellows Out Resurgent Sodium Current.

Christopher H Thompson, Jennifer A Kearney.   

Abstract

Entities:  

Year:  2016        PMID: 27857623      PMCID: PMC5106105          DOI: 10.5698/1535-7511-16.6.399

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

1.  SCN8A encephalopathy: Research progress and prospects.

Authors:  Miriam H Meisler; Guy Helman; Michael F Hammer; Brandy E Fureman; William D Gaillard; Alan L Goldin; Shinichi Hirose; Atsushi Ishii; Barbara L Kroner; Christoph Lossin; Heather C Mefford; Jack M Parent; Manoj Patel; John Schreiber; Randall Stewart; Vicky Whittemore; Karen Wilcox; Jacy L Wagnon; Phillip L Pearl; Adeline Vanderver; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2016-06-08       Impact factor: 5.864

2.  Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Mol Pharmacol       Date:  2011-07-25       Impact factor: 4.436

Review 3.  Genotype phenotype associations across the voltage-gated sodium channel family.

Authors:  Andreas Brunklaus; Rachael Ellis; Eleanor Reavey; Christopher Semsarian; Sameer M Zuberi
Journal:  J Med Genet       Date:  2014-08-27       Impact factor: 6.318

Review 4.  Genetics of the epilepsies.

Authors:  S F Berkovic; I E Scheffer
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

5.  Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Authors:  Orrin Devinsky; Eric Marsh; Daniel Friedman; Elizabeth Thiele; Linda Laux; Joseph Sullivan; Ian Miller; Robert Flamini; Angus Wilfong; Francis Filloux; Matthew Wong; Nicole Tilton; Patricia Bruno; Judith Bluvstein; Julie Hedlund; Rebecca Kamens; Jane Maclean; Srishti Nangia; Nilika Shah Singhal; Carey A Wilson; Anup Patel; Maria Roberta Cilio
Journal:  Lancet Neurol       Date:  2015-12-24       Impact factor: 44.182

6.  Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes.

Authors:  I E Scheffer; S F Berkovic
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

7.  The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.

Authors:  Dan Okura; Takafumi Horishita; Susumu Ueno; Nobuyuki Yanagihara; Yuka Sudo; Yasuhito Uezono; Takeyoshi Sata
Journal:  Anesth Analg       Date:  2014-03       Impact factor: 5.108

8.  Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A.

Authors:  Christoph Lossin; Thomas H Rhodes; Reshma R Desai; Carlos G Vanoye; Dao Wang; Sanda Carniciu; Orrin Devinsky; Alfred L George
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

9.  Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Authors:  Reesha R Patel; Cindy Barbosa; Tatiana Brustovetsky; Nickolay Brustovetsky; Theodore R Cummins
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

Review 10.  Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability.

Authors:  Janelle E O'Brien; Miriam H Meisler
Journal:  Front Genet       Date:  2013-10-28       Impact factor: 4.599

View more
  3 in total

Review 1.  Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol.

Authors:  Changqing Xu; Yumin Zhang; David Gozal; Paul Carney
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20

Review 2.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31

3.  Global alignment and assessment of TRP channel transmembrane domain structures to explore functional mechanisms.

Authors:  Katherine E Huffer; Antoniya A Aleksandrova; Andrés Jara-Oseguera; Lucy R Forrest; Kenton J Swartz
Journal:  Elife       Date:  2020-08-17       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.